Site of deposition and factors affecting clearance of aerosolized solute from canine lungs.
We determined the influence of several factors on lung solute clearance using aerosolized 99mTc-diethylenetriaminepentaacetate. We used a jet nebulizer-plate separator-balloon system to generate particles with an activity median aerodynamic diameter of 1.1 micron, administered the aerosol in a standard fashion, and determined clearance half times (t1/2) with a gamma-scintillation camera. The following serial studies were performed in five anesthetized, paralyzed, intubated, mechanically ventilated dogs: 1) control, with ventilatory frequency (f) = 15 breaths/min and tidal volume (VT) = 15 ml/kg during solute clearance; 2) repeat control, for reproducibility; 3) increased frequency, with f = 25 breaths/min and VT = 10 ml/kg; 4) positive end-expiratory pressure (PEEP) of 10 cmH2O; 5) unilateral pulmonary arterial occlusion (PAO); and 6) bronchial arterial occlusion (BAO). Control t1/2 was 25 +/- 5 min and did not change in the repeat control, increased frequency, or BAO experiments. PEEP markedly decreased t1/2 to 13 +/- 3 min (P less than 0.01), and PAO increased it to 37 +/- 6 min (P less than 0.05). We conclude that clearance from the lungs by our method is uninfluenced by increased frequency, increases markedly with PEEP, and depends on pulmonary, not bronchial, blood flow.
D000336:Aerosols; D000818:Animals; D001157:Arterial Occlusive Diseases / Q000378:metabolism; D001981:Bronchial Arteries; D004285:Dogs; D008168:Lung / Q000378:metabolism*; D008657:Metabolic Clearance Rate; D010316:Particle Size; D004369:Pentetic Acid / Q000008:administration & dosage* / Q000378:metabolism; D011175:Positive-Pressure Respiration; D011651:Pulmonary Artery; D013667:Technetium / Q000008:administration & dosage* / Q000378:metabolism; D016284:Technetium Tc 99m Pentetate; D013990:Tidal Volume; D013997:Time Factors
D000336:Aerosols; D013667:Technetium; D004369:Pentetic Acid; D016284:Technetium Tc 99m Pentetate